Principals

Scientific rigor, commercial experience, and deep translational expertise — integrated.

Denes V. Agoston, MD, PhD

Founder & Chief Scientic Officer

Project Management

Beth Carino

Beth is an international business development executive with over 30 years in life sciences, spanning clinical pathology laboratory management, project management, and marketing & business development across global preclinical CROs, academic institutions, and early-stage biotech companies. She has a proven ability to translate complex scientific capabilities into compelling investment and partnership opportunities.

Artificial Intelligence and Machine Learning

Balint Tapai

Balint is an AI specialist with expertise in computer vision, survival analysis, large language models, and predictive forecasting. With experience as Head of R&D and Tech Lead, he has a proven track record of building production-ready AI pipelines in demanding scientific environments.

SignalNeuro Partners brings together physician-scientist leadership, life sciences business development, and AI-assisted analysis to deliver assessments that purely academic or purely commercial advisors cannot replicate.

Denes is a physician-scientist with over 30 years across basic, translational, and clinical neuroscience and CNS drug development. His career spans leading institutions from the NIH to the Karolinska Institute, as well as the commercial side of neuroscience, where he has worked as a program strategist and company founder. His particular expertise in blood-and CSF-based protein biomarkers in health and disease forms a key methodological core of SignalNeuro Partners' diligence work.

Translational Neuroscience   ·   Blood & CSF Biomarkers  ·   Neuroinflammation   ·   Neural Interface Biology    ·   CNS Drug Development   ·   Neuronal Signaling   ·   Molecular Biology

That biomarker expertise extends directly to neural interface evaluation as the same molecular indicators that track CNS recovery and neuroinflammatory state are among the most sensitive measures of how neural tissue responds to implanted devices over time.

Life Sciences Marketing & Business Development   ·   Project Management & CRM ·   Clinical Pathology   ·   Preclinical CROs    ·   Investor Positioning   

Her end-to-end understanding of the translational landscape from clinical diagnostics through preclinical research and into clinical development gives her a distinctive view of where scientific evidence is strong, where the gaps lie, and what it takes to make a program investor-ready.

Computer Vision   ·   Survival Analysis ·   LLMs   ·   Predictive Forecasting    ·   Cognitive Science   

His foundation in Cognitive Science bridges the gap between advanced machine learning and the nuanced demands of neuroscience, making AI-assisted analysis an integrated component of the diligence process rather than a separate capability.